Watch: Oklahoma judge to issue landmark verdict in Johnson & Johnson $17 billion opioid trial
August 26, 2019 at 15:30 PM EDT
J&J, which marketed the opioid painkillers Duragesic and Nucynta, has denied any wrongdoing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.